HuGE Literature Finder
Records
1
-
30
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS open bio 2022 Oct . Xu Fei, Cui Wen-Qiang, Liu Cun, Feng Fubin, Liu Ruijuan, Zhang Jingtao, Sun Chang-Ga |
| Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Sep . Momeni Boroujeni Amir, Kertowidjojo Elizabeth, Wu Xinyu, Soslow Robert A, Chiang Sarah, Da Silva Edaise M, Weigelt Britta, Chui M Herm |
| Prognostic of recurrence and survival in poorly differentiated thyroid cancer. Endocrine-related cancer 2022 Aug . Hescot Segolene, Al Ghuzlan Abir, Henry Theophraste, Sheikh Alard Hala, Lamartina Livia, Borget Isabelle, Hadoux Julien, Baudin Eric, Dupuy Corinne, Nikitski Alyaksandr V, Nikiforov Yuri E, Schlumberger Martin, Nikiforova Marina N, Leboulleux Soph |
| Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Annals of surgery 2022 Jul . Newhook Timothy E, Overman Michael J, Chun Yun Shin, Dasari Arvind, Tzeng Ching-Wei D, Cao Hop S Tran, Raymond Victoria, Parseghian Christine, Johnson Benny, Nishioka Yujiro, Kawaguchi Yoshikuni, Uppal Abhineet, Vreeland Timothy J, Jaimovich Ariel, Arvide Elsa M, Cristo Jenilette V, Wei Steven H, Raghav Kanwal P, Morris Van K, Lee Jeffrey E, Kopetz Scott, Vauthey Jean-Nicol |
| Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Pathology 2022 Jun . Tsang Julia Y, Shao Yan, Poon Ivan K, Ni Yun-Bi, Kwan Johnny S, Chow Chit, Shea Ka-Ho, Tse Gary |
| Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma. Virchows Archiv : an international journal of pathology 2022 Jun . Yamashita Atsushi, Suehara Yoshiyuki, Hayashi Takuo, Takagi Tatsuya, Kubota Daisuke, Sasa Keita, Hasegawa Nobuhiko, Ishijima Muneaki, Yao Takashi, Saito Tsuyos |
| Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy. Genes & genomics 2022 May . Huh Yeon-Ju, Cho Sung-Yup, Cho Min-Sun, Lee Kyoung-Eun, Lee Joo- |
| Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer. NPJ breast cancer 2022 2 8 (1): 19. Ji Jung Hwan, Bae Soong June, Kim Kyungsoo, Chu Chihhao, Lee Kyung-A, Kim Yoonjung, Kim Jee Hung, Jeong Joon, Ahn Sung G |
| Association of Pathway Mutations With Survival in Taiwanese Breast Cancers. Frontiers in oncology 2022 12 819555. Yang Po-Sheng, Chao Ying-Ting, Lung Chun-Fan, Liu Chien-Liang, Chang Yuan-Ching, Li Ker-Chau, Hsu Yi-Chiu |
| Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation. Cancer cell international 2022 1 22 (1): 33. Quan Yongjun, Zhang Xiaodong, Ping H |
| Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 2 35 (8): 1066-1074. Stradella Agostina, Gargallo Pablo, Cejuela Mónica, Petit Anna, Bosch-Schips Jan, Carbonell Paula, Recalde Sabela, Vethencourt Andrea, Fernandez-Ortega Adela, Falo Catalina, Gil-Gil Miguel, Vázquez Silvia, Obadia Verónica, Villanueva-Vázquez Rafael, Soler-Monsó Teresa, Calabria Inés, Pernas Son |
| Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma. Journal of neuro-oncology 2022 1 156 (2): 353-363. Dono Antonio, Zhu Ping, Holmes Emma, Takayasu Takeshi, Zhu Jay-Jiguang, Blanco Angel I, Hsu Sigmund, Bhattacharjee Meenakshi B, Ballester Leomar Y, Kim Dong H, Esquenazi Yoshua, Tandon Nit |
| Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period. Hepatology international 2022 1 16 (1): 135-147. Kaibori Masaki, Sakai Kazuko, Matsushima Hideyuki, Kosaka Hisashi, Matsui Kosuke, De Velasco Marco A, Sekimoto Mitsugu, Nishio Kazu |
| Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer. Frontiers in oncology 2022 1 11 801880. Iseas Soledad, Sendoya Juan M, Robbio Juan, Coraglio Mariana, Kujaruk Mirta, Mikolaitis Vanesa, Rizzolo Mariana, Cabanne Ana, Ruiz Gonzalo, Salanova Rubén, Gualdrini Ubaldo, Méndez Guillermo, Antelo Marina, Carballido Marcela, Rotondaro Cecilia, Viglino Julieta, Eleta Martín, Di Sibio Alejandro, Podhajcer Osvaldo L, Roca Enrique, Llera Andrea S, Golubicki Mariano, Abba Martín Carl |
| Rapid recurrence of a ruptured mucinous borderline ovarian tumor harboring K-RAS mutation followed by progression into anaplastic carcinoma with TP53 mutation. Heliyon 2022 10 8 (10): e10877. Yang Yang, Guan Yanxian, Xu Manman, Liu Junx |
| The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 2022 1 11 (5): 1299-1309. Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang W |
| The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies. Frontiers in immunology 2022 10 13 1009634. Chen Lei, Zheng Yi, Jiang Changqin, Yang Cheng, Zhang Li, Liang Chaozh |
| TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma. Cancer biology & therapy 2022 12 23 (1): 439-445. Li Yong, Wu Junjun, Li Enliang, Xiao Zhouqing, Lei Jun, Zhou Fan, Yin Xiangbao, Hu Dandan, Mao Yilei, Wu Linquan, Wenjun Li |
| TTN/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients. Translational cancer research 2022 2 10 (3): 1284-1294. Xue Dan, Lin Hongguang, Lin Lan, Wei Qiongying, Yang Sheng, Chen Xiang |
| Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes: A Case Report. International journal of surgical pathology 2022 1 30 (6): 646-651. Otani Tomoyuki, Kanemura Hiroaki, Kimura Masatomo, Mitani Seiichiro, Takeda Masayuki, Matsuki Mitsuru, Matsumura Noriomi, Satou Takao, Nakagawa Kazuhiko, Ito Akihi |
| Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population. Annals of medicine 2021 Dec 53 (1): 1358-1369. Wang Liye, Zhai Qinglian, Lu Qianyi, Lee Kaping, Zheng Qiufan, Hong Ruoxi, Wang Shus |
| Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2021 Nov . Nishioka Yujiro, Paez-Arango Natalia, Boettcher Federico Oppliger, Kawaguchi Yoshikuni, Newhook Timothy E, Chun Yun Shin, Tzeng Ching-Wei D, Tran Cao Hop S, Lee Jeffrey E, Vreeland Timothy J, Vauthey Jean-Nicol |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free radical biology & medicine 2021 Oct 177 58-71. Delgobo Marina, Gonçalves Rosângela Mayer, Delazeri Marco Antônio, Falchetti Marcelo, Zandoná Alessandro, Nascimento das Neves Raquel, Almeida Karoline, Fagundes Adriane Cristina, Gelain Daniel Pens, Fracasso João Isidro, Macêdo Guilherme Baroni de, Priori Leonardo, Bassani Nicklas, Bishop Alexander James Roy, Forcelini Cassiano Mateus, Moreira José Cláudio Fonseca, Zanotto-Filho Alf |
| Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study. Breast cancer research and treatment 2021 Jun . Kim Haeyoung, Kim Yeon Jeong, Park Donghyun, Park Woong-Yang, Choi Doo Ho, Park Won, Cho Won Kyung, Kim Nal |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer. Journal of the National Cancer Institute 2021 12 114 (4): 565-570. Weber-Lassalle Konstantin, Ernst Corinna, Reuss Alexander, Möllenhoff Kathrin, Baumann Klaus, Jackisch Christian, Hauke Jan, Dietrich Dimo, Borde Julika, Park-Simon Tjoung-Won, Hanker Lars, Prieske Katharina, Schmidt Sandra, Weber-Lassalle Nana, Pohl-Rescigno Esther, Kommoss Stefan, Marmé Frederik, Heitz Florian, Stingl Julia C, Schmutzler Rita K, Harter Philipp, Hahnen Er |
| Genomic analysis for the prediction of prognosis in small-bowel cancer. PloS one 2021 16 (5): e0241454. Tsuboi Akiyoshi, Urabe Yuji, Oka Shiro, Sumioka Akihiko, Iio Sumio, Yuge Ryo, Hayashi Ryohei, Kuwai Toshio, Kitadai Yasuhiko, Kuraoka Kazuya, Arihiro Koji, Tanaka Shinji, Chayama Kazua |
| Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy. European urology 2021 12 81 (5): 466-473. Mossanen Matthew, Carvalho Filipe L F, Muralidhar Vinayak, Preston Mark A, Reardon Brendan, Conway Jake R, Curran Catherine, Freeman Dory, Sha Sybil, Sonpavde Guru, Hirsch Michelle, Kibel Adam S, Van Allen Eliezer M, Mouw Kent |
| Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma. Frontiers in oncology 2021 11 616209. Liu Tao, Yao Qianqian, Jin H |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: